NOTE F4 Other operating gains and losses
- Index
- 1 NOTE F1 Segment information
- 2 NOTE F2 Consolidated income statement by nature
- 3 NOTE F3 Revenue from non-core activities
- 4 NOTE F4 Other operating gains and losses
- 5 NOTE F5 Results from portfolio management and reassessments, legacy remediation and major litigations
- 6 NOTE F6 Net financial charges
- 7 NOTE F7 Income taxes
- 8 NOTE F8 Discontinued operations
- 9 NOTE F9 Profit for the year
- 10 NOTE F10 Earnings per share
In € million |
2017 |
2016 |
||
Start-up, formation and preliminary study costs |
(12) |
(15) |
||
Capital gains/losses on sales of property, plant and equipment and intangible assets |
19 |
21 |
||
Net foreign exchange gains and losses |
(9) |
2 |
||
Amortization of intangible assets resulting from PPA |
(206) |
(214) |
||
Other |
53 |
6 |
||
Other operating gains and losses |
(154) |
(200) |
The line “Other” in 2017 relates mainly to the reduction of the Cytec post-retirement medical obligations for €37 million following the harmonization of medical benefit plans in the Group.